Get the Stockscreener App
114.99
1.53%
-1.7771
Abivax Adr stock is traded at $114.99, with a volume of 138.23K.
It is down -1.53% in the last 24 hours and up +3.86% over the past month.
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
See More
Previous Close:
$116.77
Open:
$116.35
24h Volume:
138.23K
Relative Volume:
0.10
Market Cap:
$9.08B
Revenue:
-
Net Income/Loss:
$-159.39M
P/E Ratio:
-32.48
EPS:
-3.5401
Net Cash Flow:
$-105.22M
1W Performance:
-3.76%
1M Performance:
+3.86%
6M Performance:
+30.61%
1Y Performance:
+1,365%
1-Day Range:
$114.01
$116.45
1-Week Range:
$105.78
$122.49
52-Week Range:
$4.77
$148.83
Abivax Adr Stock (ABVX) Company Profile
Compare ABVX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABVX
Abivax Adr
|
114.88 | 9.23B | 0 | -159.39M | -105.22M | -3.5401 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.07 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
769.77 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
729.48 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.27 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
294.56 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Initiated | Truist | Buy |
| Nov-06-25 | Initiated | Wolfe Research | Outperform |
| Oct-13-25 | Initiated | Barclays | Overweight |
| Jul-23-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-20-25 | Initiated | Morgan Stanley | Equal-Weight |
| Dec-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jul-29-24 | Initiated | Laidlaw | Buy |
| May-20-24 | Initiated | BTIG Research | Buy |
| Apr-29-24 | Initiated | Guggenheim | Buy |
| Apr-29-24 | Initiated | Piper Sandler | Overweight |
| Nov-14-23 | Initiated | Leerink Partners | Outperform |
| Nov-14-23 | Initiated | Morgan Stanley | Equal-Weight |
View All
Abivax Adr Stock (ABVX) Latest News
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
TD Asset Management Inc Buys New Shares in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Short Interest Down 13.2% in February - MarketBeat
Erste Asset Management GmbH Buys New Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Envestnet Asset Management Inc. Acquires New Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat
Optiver Holding B.V. Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
Analysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Irhythm Technologies (IRTC) - The Globe and Mail
Greenland Capital Management LP Purchases Shares of 25,039 Abivax SA Sponsored ADR $ABVX - MarketBeat
Patient Square Capital LP Purchases Shares of 151,833 Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026 - GlobeNewswire Inc.
Persistent Asset Partners Ltd Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
TimesSquare Capital Management LLC Takes $10.87 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Aberdeen Group plc Has $66.85 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
ABIVAX Societe Anonyme (ABVX): A Bull Case Theory - Finviz
Federated Hermes Inc. Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
ABIVAX Societe Anonyme (ABVX) Share Momentum Builds Amid Takeover Speculation and Advancing Therapeutic Programs - Finviz
Nan Fung Trinity HK Ltd. Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
Privium Fund Management B.V. Makes New $2.58 Million Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), Ascendis Pharma (ASND) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's What You Should Know - MSN
Abivax SA Sponsored ADR (NASDAQ:ABVX) Short Interest Up 25.0% in December - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Abivax SA Sponsored ADR (ABVX) Receives a Buy from Truist Financial - The Globe and Mail
Why Abivax SA Sponsored ADR Shares Are Surging - TipRanks
FY2025 EPS Estimates for Abivax Reduced by Lifesci Capital - Defense World
ABIVAX Societe Anonyme (ABVX) Rumored To Attract Interest From Eli Lilly - Finviz
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Is ABIVAX Societe Anonyme (ABVX) One of the Hottest Large-Cap Stocks of 2025? - Finviz
Could This Potential Move Boost Eli Lilly's Prospects? - Finviz
Voya Investment Management LLC Invests $978,000 in Abivax SA Sponsored ADR $ABVX - MarketBeat
61,449 Shares in Abivax SA Sponsored ADR $ABVX Purchased by Simplify Asset Management Inc. - MarketBeat
Abivax (NASDAQ:ABVX) Shares Gap UpHere's What Happened - MarketBeat
Guggenheim Bullish on Abivax (ABVX) Ahead of Key Obefazimod Data Readout - Finviz
Abivax (NASDAQ:ABVX) Trading Up 6%Time to Buy? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and Integra Lifesciences (IART) - The Globe and Mail
Abivax (NASDAQ:ABVX) Sets New 1-Year HighHere's Why - MarketBeat
Why Abivax Stock Was on Fire Today - Finviz
Why Abivax SA Sponsored ADR Shares Are Tumbling - TipRanks
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Abivax shares gain after 22 scientific abstracts accepted for ECCO 2026 - MSN
Abivax stock rises after announcing acceptance of 22 abstracts at ECCO 2026 - Investing.com
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Novan (NOVN) - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
Citizens Jmp Issues Positive Forecast for Abivax (NASDAQ:ABVX) Stock Price - Defense World
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers - ts2.tech
Abivax (NASDAQ:ABVX) Trading Down 5.9%Should You Sell? - MarketBeat
Abivax SA Reports Increased Losses in Q3 2025 Amid Rising R&D Costs - The Globe and Mail
Abivax SA reports increased losses in Q3 2025 amid rising R&D costs - MSN
FY2025 EPS Estimates for Abivax Decreased by Lifesci Capital - MarketBeat
Abivax Adr Stock (ABVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):